pharmaphorum

AUGUST 4, 2020

A new analysis from consulting firm CRA has honed in on the different challenges faced in four European markets – England, France, Germany and Scotland – and looked at how manufacturers can increase the chances of a successful appraisal. Source: CRA Analysis. Source: CRA Analysis.

Labelling 121

Labelling 121

Omnicell

JANUARY 10, 2023

Len Hom Director, Product Marketing, Omnicell One of the most significant challenges facing businesses today is staffing, with healthcare particularly hard hit. These CEOs anticipate that a lack of labor will result in slower care delivery, restricted access to care, and lower revenue. This is not a new problem. Subscribe today.

Omnicell 95

Omnicell Controlled Substances Patient Care Hospitals 95

pharmaphorum

MARCH 25, 2022

In their meta-analysis of published studies, the authors found universal deficiencies and concluded that there’s no convincing evidence that app-based interventions deliver meaningful outcomes. I reviewed all 14 meta-analyses included in the study and found the analysis to be accurate, but incomplete.

FDA 114

FDA 114

Omnicell

JANUARY 10, 2023

Director Product Marketing & Development, Omnicell With drug costs skyrocketing and the ever-present challenge of drug shortages, throwing away medications can be agonizing. IV compounding automation and robust services that include access to low cost cGMP stability studies to support extended beyond use dating. Joy Somogyi Sr.

Omnicell 98

Omnicell Compounding 98

Omnicell

JANUARY 10, 2023

Len Hom Director, Product Marketing, Point of Care, Omnicell With billions spent on electronic health records (EHR), healthcare providers need other technology to integrate seamlessly with the EHR to create a more cohesive workflow. Disclaimer The views and opinions expressed in this blog are those of the authors. Subscribe today.

Omnicell 98

Omnicell Cerner Medication Dispensing Documentation 98

Roots Analysis

JANUARY 2, 2024

In order to build an understanding on the user sentiments related to patient engagement apps (on the iOS and Android app store), we have conducted proprietary fine-grained sentiment analysis of more than 300,000 patient reviews. What is Fine Grained Sentiment Analysis? How FINE-GRAINED Sentiment Analysis can Help App Developers?

Health and Personal Care Stores 40

Health and Personal Care Stores Medical Records Prescription Management Communication 40

Omnicell

JANUARY 10, 2023

Joy Somogyi Senior Director, Product Marketing, Omnicell One of the most renowned health systems in the country, St. Jude's pharmacists are empowered by having access to near-real-time data. Their certified registered nurse anesthetists (CRNAs) rely on regular access to those medications. The mission of St.

Omnicell 52

Omnicell Medication Dispensing Patient Care Hospitals 52

Omnicell

SEPTEMBER 5, 2022

Ngo EVP, Marketing, Strategy, and Business Development at Omnicell As more pharmacies and health systems embrace digital transformation, they now have access to powerful data sets that reveal patterns and trends that will allow them to better manage a complex medication supply chain. Read the entire Forbes article for more information.

Omnicell 52

Omnicell Hospitals 52

ISPE

AUGUST 17, 2023

The application of quality risk management to the design, validation and technology transfer of advanced production processes and analytical methods, advanced data analysis methods and computerized systems is important." For one, electronic data can be stored and accessed more easily than physical documents.

Documentation 98

Documentation 98

Pharmaceutical Technology

JULY 12, 2022

Despite the market size for B-cell non-Hodgkin’s lymphoma (NHL) being at least five times that of ALL, NHL has a smaller pipeline of cell therapies. The total market for cell therapies in oncology is projected to exceed $37bn worldwide by 2028.

FDA 52

FDA 52

Omnicell

JANUARY 10, 2023

Director Product Marketing & Development, Omnicell I recently spoke with Dr. Shafiq Rab , MBBS, MPH, CHCIO, FCHIME , Chief Digital Officer and System  CIO at Wellforce , about his perspectives on digital transformation and culturally competent care. Joy Somogyi Sr. Digital transformation is the digital way of life.

Compounding Pharmacies 52

Compounding Pharmacies Omnicell Compounding Communication 52

Omnicell

FEBRUARY 17, 2023

Dennis Wright Senior Director, Product Marketing, Omnicell For more than 15 years, IV robotics has proven efficacy in safe and efficient sterile compounding, but market adoption has been limited. Assumptions made in the analysis are not reflective of the position of any entity other than the author(s).

Omnicell 52

Omnicell Compounding Sterile Compounds Labelling 52

pharmaphorum

MAY 14, 2021

Experts from ICON give us their views on the past, present and future of NICE’s standing on the world stage. This article appears in our digital magazine, Deep Dive: Market Access 2021. This additional effort could lead to poorer patient access. “It It’s important to remember that the UK market represents only 2.5%

Documentation 58

Documentation Pharmaceutical Companies Pharmaceutical Companies 58

Pharma Marketing Network

DECEMBER 6, 2021

Direct Integrations with hundreds of leading health websites provides Tap Native access to billions of content pages for analysis. million unique URLs across the top 100 largest health websites in its network to determine which topics were viewed most. Tap Native analyzed over 2.2

Immunization 52

Immunization Vaccines 52

pharmaphorum

AUGUST 17, 2022

Access and uptake have been highlighted in particular by the ABPI, which said that “[the UK is] falling behind our global competitors when it comes to crucial areas like the use of diagnostics, patient uptake of new medicines, recruitment to clinical trials and pharmaceutical exports.” What’s in the indicators…. About the author.

58

58

Omnicell

SEPTEMBER 5, 2022

Joy Somogyi Senior Director, Product Marketing, Omnicell With exponential growth in development of novel treatments , the scope of a health system’s formulary, and the associated data, continues to expand year over year. Assumptions made in the analysis are not reflective of the position of any entity other than the author(s).

Omnicell 52

Omnicell Medical Records Hospitals 52

European Pharmaceutical Review

DECEMBER 20, 2023

The proposed changes to EU pharmaceutical legislation broadly aim to: Support innovation and boost attractiveness of EU market Ensure timely and equitable access to medicines for patients across the EU Address other ongoing issues, including antimicrobial resistance and environmental impact of medicines. analysis (Source: L.E.K)

Labelling 90

Labelling Documentation 90

Omnicell

JANUARY 10, 2023

Len Hom Director, Product Marketing, Omnicell While there are many benefits to using automated dispensing cabinets (ADCs), such as increased inventory control and efficiency in drug dispensing practices, limits on configuration and functionality combined with underutilization of safety procedures can pose serious risks.

Omnicell 52

Omnicell Inventory Control Controlled Substances Packaging 52

Omnicell

JANUARY 10, 2023

Len Hom Director, Product Marketing, Omnicell According to the Food and Drug Administration, almost 1.5 The goal is to support the safety of the medication distribution process while making required drugs readily accessible in a variety of patient care areas. million people in the U.S. are injured annually due to medication errors. 

Omnicell 52

Omnicell Documentation Labelling Patient Care 52

pharmaphorum

SEPTEMBER 17, 2020

In this issue we hear from a variety of KOLs who are leading pharma comms into a new, digital era to get their views on how pharma can best adapt for the post-COVID world. OPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means for pharma.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

FEBRUARY 11, 2022

As of 7 February, CZI’s group of 50 rare disease patient advocacy organisations can utilise Komodo’s high-fidelity data, analytics tools, Healthcare Map, and software to access information on 330 million patients with 15 million new clinical encounters daily and 150 million payer-complete profiles. The benefits of accessibility.

104

104

Omnicell

JANUARY 10, 2023

Joy Somogyi Senior Director, Product Marketing, Omnicell Modern pharmacists spend nearly a decade training for clinical practice. Pharmacists are consistently ranked among the top-most trusted professions , in large part due to their extensive training, medication expertise, accessibility, and compassion.

Omnicell 52

Omnicell Patient Care Hospitals 52

Omnicell

JANUARY 10, 2023

More than 95% of Americans live within 5 miles of a community pharmacy, making the pharmacist the most accessible and trusted healthcare provider – only nurses rank higher. Assumptions made in the analysis are not reflective of the position of any entity other than the author(s). It’s easy to see why.

Community Pharmacies 52

Community Pharmacies Patient Care Medication Dispensing Vaccines 52

Fuld

JANUARY 21, 2020

For more than 40 years, Fuld + Company has partnered with its clients to deliver strategic insights, guidance and industry analysis that support executive decision-making. Having a Fuld representative on-site extends our capabilities and expertise day-to-day, to support our clients’ specific business needs, as they arise.

Process Improvement 78

Process Improvement Documentation 78

Omnicell

SEPTEMBER 5, 2022

Director Central Pharmacy Product Marketing at Omnicell In many other industries we’ve seen success in how technology is accelerating and transforming the way products and services are created, delivered, consumed, and measured. Assumptions made in the analysis are not reflective of the position of any entity other than the author(s).

Omnicell 52

Omnicell Patient Care 52

Omnicell

SEPTEMBER 5, 2022

Joy Somogyi Senior Director of Product Marketing and Development, Omnicell With two million people suffering from opioid addiction and 115 people dying from an opioid overdose every day in the U.S., Assumptions made in the analysis are not reflective of the position of any entity other than the author(s).

Omnicell 52

Omnicell Controlled Substances Hospitals Documentation 52

Omnicell

SEPTEMBER 5, 2022

Mike Cantrell Senior Director, Regional Operations, EnlivenHealth™, an Omnicell Innovation Given the continuing effects of the COVID-19 pandemic, pharmacists are playing an increasingly important role in providing trusted, accessible and affordable healthcare.

Omnicell 52

Omnicell Medication Dispensing Community Pharmacies Vaccines 52

pharmaphorum

DECEMBER 2, 2022

With myriad new technologies and tools hitting the market, there is no doubt that digital health is transforming the way that we deliver and receive healthcare. However, as the market begins to correct itself, where does digital health go from here? Video: Frontiers Health interviews. Case study: Syneos Health and VBI Vaccines.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies Vaccines 52

pharmaphorum

NOVEMBER 2, 2020

Digital therapeutics are gaining momentum worldwide and offer developers, including pharma, both a huge opportunity and a stimulating market access challenge, say Olaf Schoeman and Emanuele Arcà. Thriving in COVID-19 with flexible marketing strategies. Germany’s digital health changes will boost digital therapeutics in Europe.

Pharmaceutical Companies 58

Pharmaceutical Companies Pharmaceutical Companies 58

pharmaphorum

NOVEMBER 11, 2020

Other promising benefits include administrative automation and population health risk analysis. AI based diagnostic image analysis is showing a lot of promise. It’s not always possible to access the data sources in an automated way. Lack of interoperability across various healthcare systems is still an issue,” he explains.

Pharmaceutical Companies 139

Pharmaceutical Companies Pharmaceutical Companies Communication Hospitals 139

pharmaphorum

AUGUST 24, 2020

Project Patient Voice is a dedicated online platform that makes patient-reported symptoms and adverse events (AEs) from the trial data of marketed drugs publicly available. . He added that it allowed people to provide information on their trial experience in a relatable, accessible manner. . Click here to view the online portal.

Labelling 128

Labelling Communication FDA 128

pharmaphorum

MAY 17, 2021

Analysis of Net Promoter Score in IQVIA’s ChannelDynamics data presents some interesting findings. There is an improvement in HCPs’ views of remote representative platform interactions with an important increase in promoters and decrease in detractors over the past 12 months. The HCP View.

Communication 72

Communication 72

Omnicell

JANUARY 10, 2023

The federal bill also provides protection to 340B providers in the Medicare Parts C and D markets, which can’t be addressed at the state level. As Ryan White Clinics for 340B Access’s (RWC-340B) President Shannon Stephenson puts it: “It’s the right thing to do. The Protect 340B Act provides a solution.

Insurance 52

Insurance Hospitals 52

pharmaphorum

APRIL 16, 2021

The launch environment was directly impacted by the COVID-19 pandemic, which hit two key drivers of launch uptake particularly hard: the dynamic market, i.e. new and switch prescriptions, and face-to-face interactive engagement with healthcare professionals. We measured the pandemic impact on the launch of NAS at four levels.

Pharmaceutical Companies 95

Pharmaceutical Companies Pharmaceutical Companies Documentation Vaccines 95

Omnicell

JANUARY 10, 2023

They include too many different sets of state rules with a patchwork of protections, and the safeguards arguably don’t apply to the Medicare market. The legislation also applies to the Medicare markets. Assumptions made in the analysis are not reflective of the position of any entity other than the author(s).

Omnicell 52

Omnicell Hospitals 52

pharmaphorum

DECEMBER 14, 2020

As this issue’s title suggests, patient centricity is about more than just talking points and marketing strategies – it requires companies to truly listen to, engage with and partner with the patients they serve, and in putting this month’s Deep Dive together it’s been great to see that so many pharma firms are now taking this to heart.

Pharmaceutical Companies 75

Pharmaceutical Companies Pharmaceutical Companies FDA 75

Omnicell

SEPTEMBER 5, 2022

Ken Osborn Senior Director, Product Marketing, Omnicell Latest Innovation in Winter 2020 Release Advances Journey to the Autonomous Pharmacy The need for solutions designed to help customers achieve greater visibility, control costs, and better manage an increasingly complex pharmacy supply chain is more important than ever.

Omnicell 52

Omnicell Controlled Substances Hospitals Patient Care 52